Effect of CCR2 chemokine receptor polymorphism on HIV type 1 mother-to-child transmission and child survival in Western Kenya

AIDS Research and Human Retroviruses

Volumn 21, Issue 5, 2005, Pages 358-362

  Brouwer, Kimberly C ^a,e   Yang, Chunfu ^b   Parekh, Shalini ^a   Mirel, Lisa B ^a   Shi, Ya Ping ^a,c   Otieno, Juliana ^d   Lal, Altaf A ^a   Lal, Renu B ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d New Nyanza Provincial General Hospital   (Kenya)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; FOLLOW UP; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; KENYA; PRIORITY JOURNAL; SERODIAGNOSIS; SUBSPECIES; SURVIVAL; SURVIVAL RATE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; KENYA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CHEMOKINE; VIRAL LOAD;

EID: 20444372981     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.358     Document Type: Article

References (28)

1. UNAIDS/WHO: AIDS epidemic update. Geneva, Switzerland. December 2003 (accessed August 7, 2004, at http://www.who.int/hiv/pub/epidemiology/epi2003/en/ ).
2. UNICEF: AIDS fact sheet: Mother-to-child transmission of HIV. New York, 2002 (accessed July 5, 2004 at http://www.unicef.org/publications/ pub_factsheet_mtct_en.pdf).
3. UNAIDS: Children and young people in a world of AIDS. Geneva, Switzerland, 2001 (accessed July 17, 2004, at http://www.unaids.org; ISBN 92-9173-114-5).
4. Yang C, Li M, Newman RD, Shi YP, Ayisi J, van Eijk AM, Otieno J, Misore AO, Steketee RW, Nahlen BL, and Lal RB: Genetic diversity of HIV-1 in western Kenya: Subtype-specific differences in mother-to-child transmission. AIDS 2003;17:1667-1674.
5. Bulterys M and Fowler MG: Prevention of HIV infection in children. Pediatr Clin North Am 2000;47:241-260.
6. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, and O'Brien SJ: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393.
7. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, and Parmentier M: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
8. Donald JA, Rudman K, Cooper DW, Baumgart KW, Garsia RJ, Gatenby PA, and Rickard KA: Progression of HIV-related disease is associated with HLA DQ and DR alleles defined by restriction fragment length polymorphisms. Tissue Antigens 1992;39:241-248.
9. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, and Ho DD: A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998;4:350-353.
10. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, and O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-965.
11. Mangano A, Kopka J, Batalla M, Bologna R, and Sen L: Protective effect of CCR2-64I and not of CCR5-delta32 and SDFI-3′A in pediatric HIV-1 infection. J Acquir Immune Defic Syndr 2000;23:52-57.
12. Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Blanche S, Delfraissy JF, and Misrahi M: CCR2B-64I chemokine receptor allele and mother-to-child HIV-1 transmission or disease progression in children. French pediatric HIV infection study group. J Acquir Immune Defic Syndr 1999;22:267-271.
13. Contopoulos-Ioannidis DG, O'Brien TR, Goedert JJ, Rosenberg PS, and Ioannidis JP: Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: A meta-analysis. J Acquir Immune Defic Syndr 2003;32:70-76.
14. Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C, Kolczak MS, Otieno JA, Misore AO, Kager PA, Lal RB, Steketee RW, and Nahlen BL: Maternal malaria infection and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004;10:643-652.
15. Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otieno JA, Misore AO, Kager PA, Steketee RW, and Nahlen BL: Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. Int J STD AIDS 2000;11:393-401.
16. van Eijk AM, Ayisi JG, ter Kuile FO, Misore A, Otieno JA, Kolczak MS, Kager PA, Steketee RW, and Nahlen BL: Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. Am J Trop Med Hyg 2001;65:623-630.
17. Glynn JR, Buve A, Carael M, Kahindo M, Macauley IB, Musonda RM, Jungmann E, Tembo F, and Zekeng L: Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr 2000;25:345-352.
18. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, Craig FE, O'Connell P, Tryon V, Clark RA, Dolan MJ, and Ahuja SK: Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998;4:786-793.
19. Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, Korber BT, Mayaux MJ, Mofenson LM, Newell ML, Shapiro DE, Teglas JP, and Wilfert CM: Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis 2001;183:539-545.
20. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, and Rowland-Jones SL: CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet 1998;351:1632-1633.
21. Newell ML, Dunn DT, Peckham CS, Semprini AE, and Pardi G: Vertical transmission of HIV-1: Maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996;10:1675-1681.
22. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, and Bryson YJ: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
23. Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S, van der Hoven L, Markakis D, Liomba GN, Chiphangwi JD, and Miotti PG: Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS 2000;14:453-459.
24. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, and Rinaldo CR Jr: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-954.
25. Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, Karanicolas R, Deutsch L, Huang Y, Lew JF, McIntosh K, Pollack H, Borkowsky W, Spiegel HM, Palumbo P, Oleske J, Bardeguez A, Luzuriaga K, Sullivan J, Wolinsky SM, Koup RA, Ho DD, and Moore JP: A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999;73:10264-10271.
26. Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, and O'Brien TR: Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: An international meta-analysis. AIDS 2003;17:1631-1638.
27. Scott GB, Hutto C, Makuch RW, Mastrucci MT, O'Connor T, Mitchell CD, Trapido EJ, and Parks WP: Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-1796.
28. Pizzo PA and Wilfert CM: Markers and determinants of disease progression in children with HIV infection. The Pediatric AIDS Siena Workshop II. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:30-44.